Although the CSO is not directly funding any researchinto anticholinesterase inhibitors, donepezil, galantamine or rivastigmine, it wouldbe pleased to consider proposals for research into Alzheimer’s disease which wouldbe subject to the usual peer and committee review.The Medical Research Council,one of the main agencies through which the UK Government supp...